2'3'-cGAMP (Sodium Salt): Benchmark STING Agonist for Innate Immunity Research

Executive Summary. 2'3'-cGAMP (sodium salt) is the endogenous cyclic dinucleotide produced by cGAS upon detection of cytosolic double-stranded DNA, serving as a direct activator of the STING pathway (Zhang et al., 2025). It binds STING with high affinity (Kd = 3.79 nM), exceeding the potency of other cyclic dinucleotides (ApexBio). This activation triggers the TBK1-IRF3 axis, culminating in type I interferon induction, crucial for antiviral and antitumor immunity (JCI 2025). 2'3'-cGAMP (sodium salt) is highly water-soluble, stable at -20°C, and is a gold-standard tool for dissecting STING-mediated signaling and screening immunotherapeutic compounds. Recent studies have clarified its role in endothelial STING signaling, vessel normalization, and immune infiltration within the tumor microenvironment, extending its translational relevance (CRISPR-CasX 2023).

Biological Rationale

2'3'-cGAMP (sodium salt) is a naturally occurring cyclic dinucleotide second messenger. It is synthesized by cyclic GMP-AMP synthase (cGAS) in response to cytosolic double-stranded DNA, typically from pathogens or cellular damage (Zhang et al., 2025). The cGAS-STING pathway forms a critical arm of the innate immune response, acting as a DNA sensor to trigger defense mechanisms. Upon production, 2'3'-cGAMP directly binds to the stimulator of interferon genes (STING) protein located in the endoplasmic reticulum membrane. This interaction is fundamental for initiating type I interferon (IFN-I) signaling, driving antiviral and antitumor immunity (PepBridge 2023). The centrality of this pathway in immune surveillance has led to intense investigation of 2'3'-cGAMP and its analogs as research tools and therapeutic candidates.

Mechanism of Action of 2'3'-cGAMP (sodium salt)

2'3'-cGAMP (sodium salt) acts by binding to the cyclic dinucleotide binding domain of STING with a dissociation constant (Kd) of 3.79 nM, which is markedly stronger than other cyclic dinucleotides such as 3'3'-cGAMP or c-di-GMP (ApexBio). Upon ligand binding, STING undergoes a conformational change and translocates from the endoplasmic reticulum to the Golgi apparatus. This translocation is essential for recruiting and activating TANK-binding kinase 1 (TBK1) and interferon regulatory factor 3 (IRF3). Once activated, IRF3 translocates to the nucleus to promote transcription of type I interferon genes, notably IFN-β.

STING activation also triggers nuclear factor-κB (NF-κB) signaling and inflammatory responses. Post-activation, STING is palmitoylated at cysteine 88/91, which is required for optimal signaling cluster formation (Zhang et al., 2025). In endothelial cells, recent data reveal that STING's role extends downstream of IFNAR signaling, where STING directly interacts with JAK1, influencing STAT pathway activity and immune cell infiltration in the tumor microenvironment. This expands the classic model of STING as solely an upstream adaptor for IFN-I induction (23-cGAMP.com), providing new mechanistic insights.

Evidence & Benchmarks

• 2'3'-cGAMP (sodium salt) displays high binding affinity for STING (Kd = 3.79 nM, pH 7.4, 25°C), surpassing other CDN ligands (ApexBio).
• Activation of STING by 2'3'-cGAMP induces robust IFN-β transcription (≥10-fold over baseline within 6 hours, in human PBMCs, 5 μM) (Zhang et al., 2025).
• Endothelial STING signaling is required for tumor vessel normalization and CD8+ T cell infiltration after 2'3'-cGAMP agonist administration (Zhang et al., 2025).
• 2'3'-cGAMP is water-soluble (≥7.56 mg/mL at 20°C), with negligible solubility in ethanol or DMSO (ApexBio).
• STING agonists, including 2'3'-cGAMP, synergize with immune checkpoint blockade in murine models, enhancing tumor rejection (CRISPR-CasX 2023).
• STING palmitoylation (Cys91) is essential for JAK1 interaction and downstream STAT activation in endothelium (Zhang et al., 2025).

Applications, Limits & Misconceptions

2'3'-cGAMP (sodium salt) has become a reference compound for activating the cGAS-STING pathway in preclinical and translational research. Key applications include:

• Screening and benchmarking STING-targeted immunotherapeutics for cancer and antiviral therapy (Copper-II-TBTA Complex 2023).
• Dissecting cell-type-specific STING signaling using purified immune, endothelial, and tumor cell models (23-cGAMP.com). This article updates their focus by providing new evidence on JAK1-STING crosstalk in endothelium.
• Tool for pathway validation in genetic or pharmacologic loss/gain-of-function experiments.
• Rational immunotherapy design by characterizing tumor microenvironment normalization and immune infiltration (CRISPR-CasX 2023). This article extends their discussion by specifying endothelial and JAK1-STAT mechanisms.

Common Pitfalls or Misconceptions

• 2'3'-cGAMP (sodium salt) is not cell-permeable by default; delivery strategies (e.g., electroporation, lipid carriers) are required for cytosolic access (ApexBio).
• It does not activate STING in species or cells lacking functional STING protein (e.g., certain knockout models).
• 2'3'-cGAMP is unstable in alkaline or aqueous solution at room temperature for extended periods; always store at -20°C as recommended.
• Not all immune responses induced by 2'3'-cGAMP are beneficial; excessive or chronic STING activation can drive inflammation and tissue damage (Zhang et al., 2025).
• Results from murine models may not always translate directly to clinical outcomes due to species differences in STING pathway regulation.

Workflow Integration & Parameters

2'3'-cGAMP (sodium salt) is supplied as a solid disodium salt, chemically defined as adenylyl-(3'→5')-2'-guanylic acid. The molecular formula is C20H22N10Na2O13P2, with a molecular weight of 718.37 g/mol (ApexBio). For in vitro studies, it is reconstituted in sterile water to ≥7.56 mg/mL. It is insoluble in ethanol and DMSO. Working concentrations typically range from 0.1–10 μM, depending on cell type and assay. For in vivo or ex vivo delivery, formulation with appropriate carriers is critical to achieve cytosolic delivery. For optimal stability, store lyophilized or reconstituted stocks at -20°C, protected from light and repeated freeze-thaw cycles.

Integrating the B8362 kit into experimental protocols allows precise interrogation of STING-dependent responses, including type I IFN induction, NF-κB activation, and downstream immune effector recruitment. Researchers should include proper controls (vehicle, inactive analogs, STING knockout) and optimize dosing for each system. For more on optimizing pathway readouts and troubleshooting, see Optimizing STING Pathway Research, which this article updates by integrating new endothelial mechanistic insights.

Conclusion & Outlook

2'3'-cGAMP (sodium salt) remains the benchmark small molecule for probing cGAS-STING pathway biology. Its high affinity, defined mechanism, and robust performance across model systems make it indispensable for immunology, cancer, and antiviral research. Recent discoveries of endothelial STING-JAK1 signaling extend its translational impact, informing next-generation immunotherapeutics and tumor microenvironment modulation strategies. For product details and ordering, refer to 2'3'-cGAMP (sodium salt). Continued research will clarify cell-type and context-specific effects, driving improved immunomodulatory therapies.